Kiadis raises €18 million in placement

Netherlands-based Kiadis Pharma NV has called on investors for the second time since June, raising €18 million to support the development of its cell therapy platform for making bone marrow transplantations safer. The company placed 2.25 million new shares with investors.

Full text available to subscribers only. Click here for information on subscribing to MedNous.